Skip to main content
    L

    Larimar Therapeutics Inc (LRMR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.00
    -0.02 (-0.66%)

    Market Cap: $313.73M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +5.72%

    Upcoming Estimates

    Reports Mar 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.38
    Range-$0.44 - -$0.33
    13 analysts
    Revenue Consensus
    N/A
    RangeN/A
    12 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-1.35xFCF Yield-74.23%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-139.60%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio3.82xQuick Ratio3.82x
    Trading Statistics
    Beta0.69Avg Volume1.37M
    52-Week High$6.4252-Week Low$1.92

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 2.9% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 58.9, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$2.67
    SMA 20$2.54
    SMA 50$2.92
    SMA 200$3.76
    EMA 10$2.72
    EMA 20$2.65
    EMA 50$2.88
    EMA 200$3.46

    MACD

    Line: 0.02Signal: -0.08Hist: 0.10

    ADX

    ADX: 22.9+DI: 32.1-DI: 18.6

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down16.0
    PSAR$2.31

    Bollinger Bands

    Upper Band$2.99
    Lower Band$2.10
    %B Position3504%(Upper)
    Band Width1.01

    RSI (14-Day)

    Neutral
    58.9

    Momentum Oscillators

    Stoch %K81.8
    Stoch %D83.0
    Williams %R-28.2
    ROC (10d)26.6%
    Momentum0.63
    CCI (20d)211.3
    MFI (14d)73.2

    Volatility Measures

    ATR (14d)$0.26(8.7%)
    StdDev (20d)0.22
    Hist Vol115.9%(High)

    Volume Flow

    VWAP$3.06
    OBV109.8M
    AD Line-5.4M
    CMF (20d)0.120

    Volume Metrics

    Avg Vol (20d)1.4M
    Vol Ratio2.0x(High)
    VWMA (20d)$2.58

    Pivot Points

    R3$3.36
    R2$3.22
    R1$3.12
    Pivot Point$2.98
    S1$2.88
    S2$2.74
    S3$2.64

    Advanced Oscillators

    TSI1.47
    Ultimate Osc59.7
    KST5.99

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about LRMR

    News

    LRMR Valuation

    GNG's valuation label for LRMR is Fairly valued.

    P/FCF
    -1.3x
    P/B
    3.1x
    All LRMR metrics

    LRMR Profitability: Margins, ROIC and FCF

    Larimar Therapeutics (LRMR) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -139.6%
    FCF yield
    -74.2%
    LRMR financial statements

    Larimar Therapeutics Competitors

    The companies most similar to Larimar Therapeutics (LRMR) include Arcturus Therapeutics Holdings, Rocket Pharmaceuticals and Protara Therapeutics.

    Sector: Healthcare

    Companies most similar to Larimar Therapeutics

    LRMR Analyst Ratings

    Larimar Therapeutics (LRMR) has a Buy consensus from 11 analysts: 11 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    11
    Strong Buy
    2
    Buy
    9
    Hold
    0
    Sell
    0
    Strong Sell
    0
    LRMR stock forecast

    LRMR Bull Case vs Bear Case

    Bull case

    • 100.0% of LRMR's analyst ratings are Buy or Strong Buy.

    Bear case

    • LRMR beat EPS estimates in 37.5% of its last 8 reported quarters.

    LRMR Earnings: Beat Rate and Next Report

    Larimar Therapeutics (LRMR) beat the EPS estimate in 3 of the last 8 quarters (37.5%). Its next report is expected on Mar 17, 2027.

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -18.2%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.38
    LRMR earnings history

    LRMR Earnings Date

    LRMR reports Mar 17, 2027. The date is estimated.

    See insider activity

    Updated Nov 16, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About LRMR

    When does LRMR report earnings?

    Larimar Therapeutics Inc (LRMR) is expected to report earnings on Mar 17, 2027.

    Does LRMR pay dividends?

    Larimar Therapeutics Inc (LRMR) does not currently pay a regular dividend.

    What is LRMR's market cap?

    Larimar Therapeutics Inc (LRMR) has a market capitalization of $313.73M with a current stock price of $3.00.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.